Algo version: 0.98b
Suven Life Sciences is listed at the NSE Exchange
Suven Life Sciences [SUVEN.NS]
NSE Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Suven Life Sciences stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Suven Life Sciences pays dividends. Last time was Monday 25th of February 2019 where the investors holding the stock on Thursday 14th of February 2019 were paid INR1.5 per share. Over the last 16 times between 2004 and 2019, Suven Life Sciences has paid INR9.29245 with an average of INR0.58 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Suven Life Sciences 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR14.88, you would have made a profit of INR135.69 per share or 911.90%

Yes, the average daily trading liquidity for Suven Life Sciences is INR588 728 thousand. You should therefore be able to get in and out of your positions relatively fast.

Suven Life Sciences has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 14.07, the company's ability to pay off the debt is good. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Suven Life Sciences to be low [0.4 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.